Stryker remains a high-quality MedTech compounder despite a rare Q1 miss driven by a temporary cyber disruption. Q1 weakness was not demand-driven; full-year guidance is unchanged and end-market demand remains healthy. Current valuation reflects temporary disruption, offering a more attractive entry into SYK, though the stock is not cheap.

seekingalpha.com - 2026-07-09 09:18:39

Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.

zacks.com - 2026-07-08 15:05:24

Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com - 2026-07-08 12:41:12

Stryker Corporation offers a compelling medtech investment, benefiting from robust industry growth and an innovation-led strategy. SYK trades at a 13% discount to fair value, with a forward P/E of 20.1 versus a 10-year average of 25.6. Consensus expects SYK's adjusted diluted EPS to compound at 11.2% annually through 2028, supporting high single-digit dividend growth.

seekingalpha.com - 2026-07-08 08:00:00

Markets have become more volatile as investors debate whether big tech companies are getting enough return on their AI spending. The S&P 500 momentum index has outperformed the wider market by more than 70% since 2024, close to levels seen during the 1990s dot-com era.

cnbc.com - 2026-07-07 11:45:33

Stryker is a Dividend Aristocrat with 32 years of increases, robust cash flow, and a strong M&A-driven growth strategy. SYK's Q1 2026 results were impacted by a cybersecurity incident, but management maintained full-year guidance and expects normalization. The stock trades at ~21x 2026E EPS, below its 5-year average, suggesting undervaluation despite recent share price declines.

seekingalpha.com - 2026-07-02 05:25:39

Stryker (NYSE:SYK | SYK Price Prediction) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results.

247wallst.com - 2026-07-01 11:14:31

Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results.

globenewswire.com - 2026-07-01 08:00:00

On June 30, 2026, Stryker Corp (SYK) shares fell 4.7% to a current price of $314.84. This decline comes in a challenging year where the stock has seen a year-to

gurufocus.com - 2026-06-30 17:10:00

Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

zacks.com - 2026-06-29 06:51:06

PORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane Lowry at the Travelers Championship in Cromwell, Connecticut, naming him a sponsored brand ambassador for its Joint Replacement division.

prnewswire.com - 2026-06-24 08:03:00

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-06-22 12:41:10

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Vistra Corp. (NYSE:VST), adding it “went too high. It's come back down.

benzinga.com - 2026-06-18 08:23:23

Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.

zacks.com - 2026-06-12 14:20:36

SYK launches TPX HD, a small bone power tool built for complex revisions, MIS and oral maxillofacial cases with higher torque and speed.

zacks.com - 2026-06-04 11:25:18

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com - 2026-06-03 12:41:04

PORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures.

prnewswire.com - 2026-06-02 09:03:00

On June 02, 2026, we present a DCF analysis for Stryker Corp (SYK) amidst its recent price performance, which has seen a decline of 14.6% year-to-date and 21.0%

gurufocus.com - 2026-06-02 07:13:00

SYK launches Pangea Plating System in Europe, completing its first London case as it broadens trauma care solutions for many fractures.

zacks.com - 2026-05-27 12:41:16

Stryker (NYSE: SYK), a global leader in medical technologies, announced today the European launch of its [url="]Pangea Plating System[/url], a plating platform

gurufocus.com - 2026-05-26 03:00:00

AMSTERDAM--(BUSINESS WIRE)--Stryker announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.

businesswire.com - 2026-05-26 02:10:00

CHARLEVOIX, Mich.--(BUSINESS WIRE)--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in.

businesswire.com - 2026-05-19 05:30:00

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enrollment of the first patient in its first-in-human (FIH) study for Pulsatile Intravascular Lithotripsy (PIVL) therapy in a coronary indication. The POWER CAD I study will evaluate the feasibility of the Pulse IVL™ System for the treatment of patients with moderate to severely calcified coronary arteri.

businesswire.com - 2026-05-18 16:15:00

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks is more attractive to value investors?

zacks.com - 2026-05-18 12:41:15

Surgical robotics is quietly becoming an artificial intelligence story. Every robotic procedure generates structured video, kinematic, and outcomes data that platforms feed back into surgeon training, intraoperative guidance, and predictive analytics.

247wallst.com - 2026-05-15 11:45:59

Stryker Corporation (SYK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 19:20:48

On May 12, 2026, we present a DCF analysis for Stryker Corp (SYK), a company that has faced notable price performance challenges recently, with a year-to-date d

gurufocus.com - 2026-05-12 07:32:00

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker.

globenewswire.com - 2026-05-07 16:05:00

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.

globenewswire.com - 2026-05-07 08:00:00

Stryker Corporation  (NYSE:SYK) shares are trading sideways on Monday. But that wasn't the case on Friday.

benzinga.com - 2026-05-04 10:20:21

SYK misses Q1 earnings and revenue estimates as a cyber incident disrupts production, dents margins, and slows growth despite gains across key segments.

zacks.com - 2026-05-01 11:31:27

Portage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Spencer Stiles, President and Chief Operating Officer, Jason Beach, Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology and Nick Mead, Vice President, Investor Relations.

globenewswire.com - 2026-05-01 08:00:00

Organic Sales Growth: 2.4% worldwide, 1.9% in the US, 3.9% internationally.Adjusted Earnings Per Share (EPS): $2.60, down 8.5% from the previous year.Adjusted

gurufocus.com - 2026-05-01 02:19:00

Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript

seekingalpha.com - 2026-05-01 00:41:32

While the top- and bottom-line numbers for Stryker (SYK) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-04-30 19:01:06

Stryker (SYK) came out with quarterly earnings of $2.6 per share, missing the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.84 per share a year ago.

zacks.com - 2026-04-30 18:30:15

U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit ​and revenue, weighed down by softer demand for implants ‌and devices used in complex procedures ranging from spinal to orthopedic surgeries.

reuters.com - 2026-04-30 17:40:48

The medical-device company posted a profit of $745 million, up from $654 million in the same quarter a year ago.

wsj.com - 2026-04-30 16:33:00

Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billion Organic net sales increased 2.4% Reported operating income margin of 15.5% Adjusted operating income margin (1) contracted 180 bps to 21.1% Reported EPS increased 14.2% to $1.93 Adjusted EPS (1) decreased 8.5% to $2.60   First Quarter Net Sales Growth Overview   Reported   Foreign Currency Exchange   Constant Currency   Acquisitions / Divestitures   Organic MedSurg and Neurotechnology         5.0         %           1.4         %           3.6         %           2.7         %           0.9         % Orthopaedics         0.1                     1.9                     (1.8)                    (5.9)                    4.1           Total         2.6         %           1.6         %           1.0         %           (1.4)            %           2.4         % “I am pleased with our team's ability to recover quickly from the cyber incident and continue delivering for our customers and their patients,” said Kevin A. Lobo, Chair and CEO.

globenewswire.com - 2026-04-30 16:05:00

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

globenewswire.com - 2026-04-30 09:03:00

SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.

zacks.com - 2026-04-28 09:50:31

Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.

zacks.com - 2026-04-27 10:15:14

Comerica Bank cut its position in shares of Stryker Corporation (NYSE: SYK) by 6.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 114,913 shares of the medical technology company's stock after selling 7,424 shares during the period. Comerica Bank's

defenseworld.net - 2026-04-27 05:58:59

D.A. Davidson and CO. trimmed its position in Stryker Corporation (NYSE: SYK) by 3.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85,846 shares of the medical technology company's stock after selling 2,996 shares during the period. D.A. Davidson and

defenseworld.net - 2026-04-27 05:13:03

Calamos Advisors LLC increased its holdings in shares of Stryker Corporation (NYSE: SYK) by 13.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 112,881 shares of the medical technology company's stock after acquiring an additional 13,120 shares during the quarter.

defenseworld.net - 2026-04-25 03:56:55

PHILADELPHIA, April 24, 2026 (GLOBE NEWSWIRE) -- National plaintiffs' law firm  Berger Montague PC advises shareholders of Stryker Corporation (NYSE: SYK) (“Stryker” or the “Company”) about an investigation into Stryker's Board of Directors (the “Board”) for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation focuses on whether the Board failed to exercise appropriate oversight regarding its cybersecurity and data protection practices, including the Company's response to a recent cyber incident affecting its operations and data environment.

globenewswire.com - 2026-04-24 08:50:00

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-23 11:03:02

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-04-23 10:51:08

Philadelphia, Pennsylvania--(Newsfile Corp. - April 22, 2026) - National plaintiffs' law firm Berger Montague PC advises shareholders of Stryker Corporation (NYSE: SYK) ("Stryker" or the "Company") about an investigation into Stryker's Board of Directors (the "Board") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation focuses on whether the Board failed to exercise appropriate oversight regarding its cybersecurity and data protection practices, including the Company's response to a recent cyber incident affecting its operations and data environment.

newsfilecorp.com - 2026-04-22 12:16:00

Foresight Capital Management Advisors Inc. bought a new stake in shares of Stryker Corporation (NYSE: SYK) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,010 shares of the medical technology company's stock, valued at approximately $1,058,000. Several other large investors

defenseworld.net - 2026-04-22 04:45:28